Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
ACS Omega
|
May 8, 2018
Integration of Magnetic Bead-Based Cell Selection into Complex Isolations
Hannah M Pezzi, David J Niles, Jennifer L Schehr, et al.
Immunology
|
May 13, 2024
Human CD4<sup>+</sup> iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma
Dana C Baiu, Akshat Sharma, Jennifer L Schehr, et al.
Lab on a Chip
|
October 19, 2018
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extraction
Hannah M Pezzi, David J Guckenberger, Jennifer L Schehr, et al.
JCO Precision Oncology
|
February 13, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma
Vincent T Ma, Alice Y Zhou, Amir Forati, et al.
Pigment Cell & Melanoma Research
|
June 3, 2025
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma
Matthew C Mannino, Shuang G Zhao, Benjamin K Gibbs, et al.
Plos One
|
July 27, 2016
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 10, 2023
Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial
Michael F Bassetti, Brett A Morris, Nan Sethakorn, et al.
Nucleic Acids Research
|
December 5, 2021
BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity
Eui-Jun Kim, Peng Liu, Shengjie Zhang, et al.
Biomarker Research
|
April 26, 2022
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer
Jennifer L Schehr, Nan Sethakorn, Zachery D Schultz, et al.
Molecular Oncology
|
February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Rory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
ACS Omega
|
May 8, 2018
Integration of Magnetic Bead-Based Cell Selection into Complex Isolations
Hannah M Pezzi, David J Niles, Jennifer L Schehr, et al.
Immunology
|
May 13, 2024
Human CD4<sup>+</sup> iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma
Dana C Baiu, Akshat Sharma, Jennifer L Schehr, et al.
Lab on a Chip
|
October 19, 2018
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extraction
Hannah M Pezzi, David J Guckenberger, Jennifer L Schehr, et al.
JCO Precision Oncology
|
February 13, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma
Vincent T Ma, Alice Y Zhou, Amir Forati, et al.
Pigment Cell & Melanoma Research
|
June 3, 2025
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma
Matthew C Mannino, Shuang G Zhao, Benjamin K Gibbs, et al.
Plos One
|
July 27, 2016
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 10, 2023
Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial
Michael F Bassetti, Brett A Morris, Nan Sethakorn, et al.
Nucleic Acids Research
|
December 5, 2021
BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity
Eui-Jun Kim, Peng Liu, Shengjie Zhang, et al.
Biomarker Research
|
April 26, 2022
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer
Jennifer L Schehr, Nan Sethakorn, Zachery D Schultz, et al.
Molecular Oncology
|
February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Rory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
Page
of 2